Cleveland Clinic lung cancer specialists are nationally recognized for diagnosing and treating lung and chest cancers through our Chest Cancer Center and Lung Nodule Clinic. Our team provides the newest medical and surgical treatment options available for lung cancer today with survival rates of patients consistently five to 20 percent higher than the national average.
Chest Cancer Center
The Chest Cancer Center at Cleveland Clinic, which includes specialists from the Respiratory Institute, Taussig Cancer Institute, Imaging Pathology and Miller Family Heart & Vascular Institute, uses a multidisciplinary approach to cancer care. This allows us to focus our entire team’s expertise and energy on providing the best outcomes for our patients. Patients with lung cancer, mesothelioma and rare tumors of the chest wall and mediastinum (mid-chest cavity), can benefit from this comprehensive, coordinated care.
Our team includes medical oncologists, radiation oncologists, radiologist, pathologists, pulmonologists and thoracic surgeons who work together to provide the most advanced medical and surgical treatment options available for lung cancer today. We’ve designed our services so that patients can see all of the specialists they need in an efficient and timely manner.
While there is no one solution for treating lung cancer, there are many options. We help patients find the most effective treatments, allowing them to enjoy the best quality of life possible. Sometimes this means participating in a clinical trial which gives patients with all stages of lung cancer the opportunity to participate in novel treatment protocols involving surgery, radiation and/or promising chemotherapeutic agents or biologic response modifiers, not widely available elsewhere. With innovative treatments and excellent outcomes, Cleveland Clinic lung cancer specialists are nationally recognized.
Lung Nodule Clinic
Any patient with a lung nodule discovered by their physician on CT imaging or chest x-ray can be referred to our Lung Nodule Clinic. Patients will meet with physician assistants, pulmonologists, and sometimes, thoracic surgeons, who have extensive knowledge of lung nodule management. Our services include initial consultations, reviews of CT images, risk calculation and volumetric analysis of pulmonary nodules, surgical and non-surgical biopsies and advanced bronchoscopy with guided technology.
Lung Cancer Screening
Cleveland Clinic is now screening for lung nodules. The screening can help the physician and patient look for signs of lung cancer before the disease has caused someone to have symptoms. The goal of screening is to detect the disease early in its course, when it is easier to treat. Learn more about lung cancer screening.
Make an Appointment
To make an appointment with one of our lung cancer specialists, please call 216.444.6503 or toll-free at 800.223.2273, ext. 46503.
Lung cancer is an abnormal mass or tumor within the lungs. Cigarette smoking is the most common risk factor for developing lung cancer, though 25 percent of all cases of lung cancer worldwide are diagnosed in people who have never smoked.
Lung cancer is the most common malignancy worldwide, with more than one million cases diagnosed yearly. In the United States, an estimated 200,000 new cases were diagnosed in 2009 and more than 150,000 deaths were due to lung cancer – making it the leading cause of cancer death in both men and women.
Lung Cancer Treatment Guide
Download our free Lung Cancer Treatment Guide to learn more about lung cancer and the possible medical and surgical treatment options including:
- What you need to know about lung cancer
- How lung cancer is diagnosed and managed
- Stages of lung cancer
- Types of lung cancer
- Treatment options
- Clinical trials
- Patient services
Types of Lung and Chest Cancers
About 90 percent of lung cancers start in the lining of the bronchi (air passageways branching off the trachea, or breathing tube). Lung cancer also can form in glands below the lining of the bronchi, frequently in the outer edges of the lungs. These lung cancers are one of two major types, small cell or non-small cell lung cancer, each of which grows and spreads in different ways.
For More Information
Benign Lung Tumors
- Hamartoma Tumors and Papilloma Tumors
Rare Cancers of the Lungs and Chest
There are more than a dozen kinds of uncommon tumors that can develop in the chest, which may or may not arise from the lung. Some of the less common types include carcinoid tumors (often located in a large airway), and malignant mesothelioma that develops from the pleura, or lining of the lung.
For More Information
Treatments for Lung Cancer
Cleveland Clinic Chest Cancer Center's Lung Cancer Program offers several treatment options for cancers and tumors of the lungs and chest, including:
Chemotherapy and Targeted Therapies
Chemotherapy is the use of drugs that are designed to kill rapidly growing cells such as cancer cells. Chemotherapy may be injected directly into a vein (by IV, or intravenously) or given through a catheter, which is a thin tube placed into a large vein and kept there until it is no longer needed. Some chemotherapy drugs are taken by pill.
Targeted agents are a newer class of drugs that are designed to act against specific weaknesses in cancer cells or surrounding supportive tissues such as blood vessels. These drugs can also be taken by pill or by IV.
Radiation therapy is a form of high energy X-ray that kills cancer cells. It can be used as a primary treatment, or in combination with chemotherapy (with or without surgery). It often can play an important role in the care of patients with advanced cancer by providing relief from pain, blockage of the airways, shortness of breath or coughing.
Radiation therapy is a “focused” treatment, meaning it is designed to maximize its effect on the cancer cells while minimizing any injury to normal cells. Radiation to treat lung cancer most often comes from a machine (external radiation). Occasionally, the radiation may be delivered internally using tubes that place a radioactive seed directly into or near the tumor (internal radiation or brachytherapy).
Surgery is still considered the “gold standard” for treating early stage lung cancer. Removing the tumor and surrounding lung tissue gives the best chance for cure for patients whose disease is localized. Surgery should be performed by specialized thoracic surgeons with particular expertise in treatment of lung cancer and other chest malignancies. All of our thoracic surgeons at Cleveland Clinic focus specifically on chest malignancies.
Research & Clinical Trials
At Cleveland Clinic, we are constantly striving to find new ways of helping patients with lung cancer through research and clinical trials.
Lung Cancer Blood and Urine Bank Development
The purpose of this study is to gather blood and urine samples from people who either are at risk of having lung cancer or have been proven to have lung cancer, so that these samples can be used to develop lung cancer tests. The tests developed might be able to predict who will develop lung cancer in the future, or could help doctors diagnose lung cancer. Blood and urine will be collected and stored at -70° C pending worthy projects. Freezer space has been obtained in the lab of Daniel Culver, DO. ELIGIBILITY: (1) Patients ages 40-90 years, ≥ 10 pack year history; (2) untreated, tissue-confirmed lung cancer, or high suspicion of lung cancer; (3) high risk for lung cancer due to smoking, family history and COPD. Exclusion criteria include any cancers within the past 5 years, any history of lung cancer, immunosuppressive therapy or continuous supplemental oxygen use.
PRINCIPAL INVESTIGATOR: Peter Mazzone, MD, MPH
STUDY COORDINATOR: Meredith Seeley | 216.445.9557
Pragmatic Trial of More Versus Less Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
In conjunction with the Patient Centered Outcomes Research Institute (PCORI) and Kaiser Permanente of California, the main objective of the “Pragmatic trial of more versus less intensive strategies for active surveillance of patients with small pulmonary nodules,” also known as the “Lung Nodule Surveillance Trial (LNST),” compares two protocols for lung nodule evaluation, with cluster randomized assignment to treatment groups at the level of the hospital or health system. The design of the trial is a hospital-based cluster randomized trial of more frequent surveillance versus less frequent surveillance of pulmonary nodules, and immediate or delayed participation in quality improvement collaboratives. Existing medical information systems at each facility will be used to passively enroll patients in the trial. Patients will be enrolled at the time they undergo chest commuted tomography and are found to have a pulmonary nodule of the appropriate size range that meets our inclusion criteria, and who otherwise do not have exclusion criteria (such as no known lung cancer).
PRINCIPAL INVESTIGATOR: Peter Mazzone, MD, MPH
STUDY COORDINATOR: Christopher Estling | 216.445.8951
Search Lung Cancer Clinical Trials
For an accurate listing of open lung cancer clinical trials, click on the following links:
Lung Cancer Clinical Trials
For some patients, participating in a clinical trial may be the best treatment choice. Clinical trials are done to find out if new cancer treatments are safe and effective, or to see if they are better than the standard treatment. Many of today’s standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.
Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move medical knowledge forward.
There are a number of trials available for patients with lung cancer at Cleveland Clinic. These trials provide patients access to novel or experimental testing and treatment that may not be offered at other institutions. For more information about lung cancer clinical trials at Cleveland Clinic, visit the clinical trials listing.
For Medical Professionals
Our secure online service, Dr.Connect, provides referring physicians access to patient’s treatment progress with streamlined communication from Cleveland Clinic physicians to your office, allowing continued participation in the ongoing care of patients. With the best possible treatment plans and coordinated care, our team approach benefits both the patient and the referring physician.
Lung Cancer Screening Referral Form
To refer a patient to the Lung Cancer Screening Program at Cleveland Clinic, please complete the following form. If you have any questions, please call the Lung Cancer Screening Program at 216.445.3800.
Patients must meet all the following criteria to be eligible for the screening.
- Have a 30 pack year history of smoking (cigarettes only)
- Ages 55-77
- Have smoked within the past 15 years
- Have no signs or symptoms of cancer
- Healthy enough and willing to undergo curative intent treatment